COLL (STOCKS)
Collegium Pharmaceutical, Inc. Common Stock
$28.150000
+2.450000 (+9.53%)
Prev close: $25.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Vikram Karnani
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $916.44M
- Employees
- 357
- P/E (TTM)
- 20.82
- P/B (TTM)
- 2.68
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$1.92 | $1.75 | +0.1705 | +9.75% |
|
Mar 2026 (Q1)
|
$1.76 | $1.62 | +0.1368 | +8.43% |
|
Dec 2025 (Q4)
|
$2.04 | $2.37 | -0.3342 | -14.08% |
|
Sep 2025 (Q3)
|
$2.25 | $2.08 | +0.1651 | +7.92% |
Financial Statements
| Revenues | $808.21M |
| Benefits Costs and Expenses | $730.53M |
| Cost Of Revenue | $323.12M |
| Costs And Expenses | $730.53M |
| Gross Profit | $485.09M |
| Operating Expenses | $327.65M |
| Selling, General, and Administrative Expenses | $327.69M |
| Operating Income/Loss | $157.44M |
| Income/Loss From Continuing Operations After Tax | $47.92M |
| Income/Loss From Continuing Operations Before Tax | $77.68M |
| Income Tax Expense/Benefit | $29.77M |
| Income Tax Expense/Benefit, Deferred | -$30.33M |
| Net Income/Loss | $47.92M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $47.92M |
| Net Income/Loss Available To Common Stockholders, Basic | $47.92M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.52 |
| Diluted Earnings Per Share | $1.28 |
| Basic Average Shares | 95,499,556 |
| Diluted Average Shares | 111,791,506 |
| Assets | $2.14B |
| Current Assets | $608.01M |
| Inventory | $113.27M |
| Other Current Assets | $494.75M |
| Noncurrent Assets | $1.53B |
| Fixed Assets | $10.65M |
| Intangible Assets | $1.19B |
| Other Non-current Assets | $331.04M |
| Liabilities | $1.82B |
| Current Liabilities | $589.86M |
| Accounts Payable | $9.24M |
| Wages | $5.47M |
| Other Current Liabilities | $575.15M |
| Noncurrent Liabilities | $1.23B |
| Equity | $311.91M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $311.91M |
| Liabilities And Equity | $2.14B |
| Net Cash Flow From Operating Activities | $329.92M |
| Net Cash Flow From Operating Activities, Continuing | $329.92M |
| Net Cash Flow From Investing Activities | -$551.90M |
| Net Cash Flow From Investing Activities, Continuing | -$551.90M |
| Net Cash Flow From Financing Activities | $234.11M |
| Net Cash Flow From Financing Activities, Continuing | $234.11M |
| Net Cash Flow | $12.13M |
| Net Cash Flow, Continuing | $12.13M |
| Comprehensive Income/Loss | $47.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $47.55M |
| Other Comprehensive Income/Loss | -$364.00K |
| Other Comprehensive Income/Loss Attributable To Parent | -$337.00K |